http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009326432-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf3447cc50aa068a09c63438e621deca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc37124bfdb7edfdcbecf4eb37b3952d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_152077b834f66c1240da4db80b9e1408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e28be6180d4d4600daa626532aa2241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c0938dd2bda075c9333d9d97c11b8f3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
filingDate 2008-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b97e415afe0647dbbe33263b2fc8b7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33b22a49e9b0d61856c6c213e33b0f7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f122e5aa1b1b9467d98b6746cb980f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3b4fd9c336c73642f8b6988b39b9a24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef06e167b6b15a063697e566c400a8c7
publicationDate 2009-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009326432-A1
titleOfInvention Ocular implant
abstract The present invention relates to an ocular implant, particularly a glaucoma stent. n It is the object of the present invention to devise an ocular implant which allows the ocular eye pressure to be regulated, i.e., to be maintained at a desired level, while preventing the flow resistance from increasing over time, for example due to fibrosis. n In order to achieve this object, the ocular implant according to the invention comprises a small tube ( 5 ), the wall surface ( 3 ) of which encloses a hollow duct that is open on both sides in the longitudinal direction of the hollow duct, wherein a first opening ( 1 ) allowing ocular humor to flow in and a second opening ( 2 ) allowing the ocular humor to be discharged is provided, and wherein the wall surface ( 3 ) is formed by a liquid-tight material, and wherein at least one pressure-controlled valve ( 4 ) is disposed in the area of the wall surface ( 3 ).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020527415-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9370444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485701-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10245178-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9592151-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10271989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9827143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285853-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11523938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188551-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987472-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10524958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11559430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10206813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7191398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8915877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10342702-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492320-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485702-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197780-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962290-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10492950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10517759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10369050-B2
priorityDate 2007-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005125003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003135149-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6508779-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23931
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945

Total number of triples: 62.